VR Logo

Ranbaxy Laboratories Ltd. download report


Healthcare | Drugs & Pharma

Ranbaxy Laboratories Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2014 Ranbaxy Laboratories Ltd. Annual Report
2012 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2011 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2010 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2009 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2008 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2007 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2006 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2005 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2004 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2003 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2002 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2001 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
2000 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
1999 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
1998 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes
1997 Ranbaxy Laboratories Ltd. Annual Report Ranbaxy Laboratories Ltd. chairman speech Ranbaxy Laboratories Ltd. director's report Ranbaxy Laboratories Ltd. management discussion Ranbaxy Laboratories Ltd. corporate governance Ranbaxy Laboratories Ltd. auditor's report Ranbaxy Laboratories Ltd. account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1961

Chairman: Tsutomu Une

Managing Director: Arun Sawhney

Group: MNC

Listing: BSE: 500359, NSE: RANBAXY

Country: India

Headquarters: Mohali, Punjab

Website: www.ranbaxy.com

Key Facts

Market cap: ₹36,602.80 Cr

Revenue (TTM): ₹5,759.40 Cr

Earnings (TTM): ₹-1,073.21 Cr

Cash: ₹285.88 Cr

Total Debt: ₹6,597.86 Cr

Promoters' ownership: 63.22%

Liquidity:

52 Week range: ₹-- - --

Face value: ₹5.00

Shares outstanding: 42,56,63,497

10 Years Aggregate:

  • CFO: ₹2,039.65 Cr
  • EBITDA: ₹8,416.45 Cr
  • Net Profit: ₹152.79 Cr

Stock Performance

Time Period Ranbaxy Laboratories S&P BSE Sensex* S&P BSE Healthcare*
YTD36.92-8.99-17.55
1 month20.75-3.40-3.85
3 months36.92-8.50-11.97
1 Year135.630.89-15.43
3 Years22.3510.4118.79
5 Years12.5811.439.09
10 Years5.4811.7712.12
As on 01-Apr-2015 *As on 30-Jun-2022
Year Ranbaxy Laboratories S&P BSE Sensex S&P BSE Healthcare
201435.7329.8947.43